Samsung Biologics Co Ltd
KRX:207940
Wall Street
Price Targets
Price Targets Summary
Samsung Biologics Co Ltd
According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 1 044 285.71 KRW with a low forecast of 757 500 KRW and a high forecast of 1 312 500 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Samsung Biologics Co Ltd's stock price target?
Price Target
1 044 285.71
KRW
According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 1 044 285.71 KRW with a low forecast of 757 500 KRW and a high forecast of 1 312 500 KRW.
What is Samsung Biologics Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Samsung Biologics Co Ltd's revenue is 59%. The projected CAGR for the next 3 years is 15%.
What is Samsung Biologics Co Ltd's Operating Income forecast?
Projected CAGR
19%
The compound annual growth rate of Samsung Biologics Co Ltd's operating income for the next 3 years is 19%.
What is Samsung Biologics Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 8 years the compound annual growth rate for Samsung Biologics Co Ltd's net income is -10%. The projected CAGR for the next 3 years is 21%.